Groundbreaking Study Shows NAD⁺ Restores Memory in Alzheimer’s Models

Groundbreaking Study Shows NAD⁺ Restores Memory in Alzheimer’s Models

by Martina Liuhola | Nov 26, 2025 | News

A newly published study reveals that NAD⁺ can restore memory in Alzheimer’s disease models by correcting RNA splicing errors. This groundbreaking international research demonstrates how boosting this essential metabolic molecule improves memory and neuronal function...
NADMED Selected for US Market Entry Program in Collaboration with Mayo Clinic

NADMED Selected for US Market Entry Program in Collaboration with Mayo Clinic

by Martina Liuhola | Sep 12, 2025 | News

NADMED has been selected to join the prestigious AMPlify program, a U.S. market entry initiative jointly organized by Mayo Clinic and Business Finland. The program combines world-class clinical expertise, valuable market knowledge, and extensive networks to support...

Contact us!

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Clear Signature
Consent*

NADMED Ltd.
Biomedicum 2U
Tukholmankatu 8
00290 Helsinki
FINLAND

OFFICE
+358 (0)10 375 1180
info@nadmed.com
LABORATORY
+358 (0)10 375 1181
laboratory@nadmed.com
IN COLLABORATION WITH
Collaboration between Upgraded and Nadmed
Collaborarion between Nadmed and Terkko Health Hub
Collaboration with Nadmed and Biotype
Collaboration between Upgraded and Nadmed
Collaborarion between Nadmed and Terkko Health Hub
Collaboration with Nadmed and Biotype
Collaboration between Upgraded and Nadmed
Collaborarion between Nadmed and Terkko Health Hub
Collaboration with Nadmed and Biotype

Copyright 2022 NADMED | Business ID: FI3259265–3 |  Privacy policy

Website: Amanda Visuals | HilMa Oy